Solactive launches index on genomics


Solactive has released the Solactive Genomics Index, which serves as the underlying for the Global X Genomics & Biotechnology ETF. The ETF enables investors to specifically invest in companies that are pioneers in Genomics. The underlying index tracks the price movements in shares of companies that are active in the fields such as gene editing, genomic sequencing, development and testing of genetic medicine or therapies, and genetic diagnostics or biotechnology. To develop this index, Solactive utilised its proprietary Natural Language Processing algorithm ARTISÂ®. The Global X Genomics & Biotechnology ETF will be listed on NASDAQ on 9 April2019.